“一带一路”背景下中医药企业的国际化发展研究
|
摘要
"一带一路"倡议为中医药的国际化发展提供了机遇,国际化是中医药企业实现做大做强的一条重要途径。文章在介绍"一带一路"倡议决策和"一带一路"给中医药发展带来的机遇基础上,通过分析中医药行业的现状和发展趋势,结合中医药的自身特色,针对中医药企业如何实现国际化发展的问题提出了循序渐进、稳步开展、兼并重组、实现集约化等相关对策建议,希望对中医药企业有所启发。
The Belt and Road Initiative provides an opportunity for the internationalization of Chinese medicine. Internationalization is an important way for Chinese medicine enterprises to become bigger and stronger.Based on the introduction of the strategic decision of The Belt and Road and the opportunities brought by The Belt and Road for the development of Chinese medicine, the article analyzes the status quo and development trend of Chinese medicine industry,and then puts forward some countermeasures and suggestions on how to achieve the internationalization of traditional Chinese medicine enterprises, such as gradual and steady progress,mergers and acquisitions and intensification,combining with the characteristics of Chinese medicine,hoping to give some inspirations to Chinese medicine enterprises.
The Belt and Road Initiative provides an opportunity for the internationalization of Chinese medicine. Internationalization is an important way for Chinese medicine enterprises to become bigger and stronger.Based on the introduction of the strategic decision of The Belt and Road and the opportunities brought by The Belt and Road for the development of Chinese medicine, the article analyzes the status quo and development trend of Chinese medicine industry,and then puts forward some countermeasures and suggestions on how to achieve the internationalization of traditional Chinese medicine enterprises, such as gradual and steady progress,mergers and acquisitions and intensification,combining with the characteristics of Chinese medicine,hoping to give some inspirations to Chinese medicine enterprises.
引文
[1]胡长生.中国模式软实力:从增长模式到发展模式[J].中国井冈山干部学院学报,2009(4):88-94.
[2]柯尊洪.加快推进我国医药产业国际化[J].中国人大,2017(19):51.
[3]柳燕,于志斌,姜丽,等.2014年中药商品进出口分析[J].中国现代中药,2015,17(3):257-261.
[4]李辉,刘伟洪.结构进一步优化新动能正在积聚今年上半年医药进出口形势整体向好[J].中国食品药品监管,2017(9):21-23.
[5]李荣,李瑞锋.我国中药出口贸易现状及对策建议[J].商场现代化,2013(1):87-90.
[6]华东,刘赛,张国英.跨国制药公司研发国际化对我国医药行业技术外溢效应及制约因素探讨[J].中国药物经济学,2010(6):63-66.
[7]王峰.做好做强做大——中国药业迈向国际化之路[J].医药产业资讯,2005(7):84-86
[8]李栋华,卞鹰.医药行业并购研究述评[J].改革与战略,2008(9):169-171.
[9]对话中国医药行业如何“走出去”——企业需要金融和创新“两条腿走路”[J].中国战略新兴产业,2015(18):43-44.
[10]张慧.论生物制药领域国际化背景下我国药企的应对策略[J].生物技术世界,2014(4):89.
[11]李雯.跨境电子商务B2B发展模式分析[D].吉林大学,2017.
[14]周静,林江.浅谈中药企业的现代化国际化发展策略[J].广西中医学院学报,2008(1):135-136.
[15]袁嘉阳.中国企业海外投资风险与防范的法律分析[D].复旦大学,2013.
[2]柯尊洪.加快推进我国医药产业国际化[J].中国人大,2017(19):51.
[3]柳燕,于志斌,姜丽,等.2014年中药商品进出口分析[J].中国现代中药,2015,17(3):257-261.
[4]李辉,刘伟洪.结构进一步优化新动能正在积聚今年上半年医药进出口形势整体向好[J].中国食品药品监管,2017(9):21-23.
[5]李荣,李瑞锋.我国中药出口贸易现状及对策建议[J].商场现代化,2013(1):87-90.
[6]华东,刘赛,张国英.跨国制药公司研发国际化对我国医药行业技术外溢效应及制约因素探讨[J].中国药物经济学,2010(6):63-66.
[7]王峰.做好做强做大——中国药业迈向国际化之路[J].医药产业资讯,2005(7):84-86
[8]李栋华,卞鹰.医药行业并购研究述评[J].改革与战略,2008(9):169-171.
[9]对话中国医药行业如何“走出去”——企业需要金融和创新“两条腿走路”[J].中国战略新兴产业,2015(18):43-44.
[10]张慧.论生物制药领域国际化背景下我国药企的应对策略[J].生物技术世界,2014(4):89.
[11]李雯.跨境电子商务B2B发展模式分析[D].吉林大学,2017.
[14]周静,林江.浅谈中药企业的现代化国际化发展策略[J].广西中医学院学报,2008(1):135-136.
[15]袁嘉阳.中国企业海外投资风险与防范的法律分析[D].复旦大学,2013.